CompletedNot Applicable

Psychiatry of Transition in a World in Transition

Belgium252 participantsStarted 2020-06-10

Plain-language summary

This clinical study evaluates risk and protective factor to develop psychopathology in transitional age youth. 300 patients will be recruited at the age of 17 years old and assessed at baseline and 2 years later.

Who can participate

Age range17 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * French-speaking and French-understanding * Subjects who accepted to participated to the study (signature of informed consent/assent document from subjects and parents or legal holder of parental authority) * Specific criteria for patients: inpatients and out-patients * Specific criteria for control group: youth from general population or placed in residential centres Exclusion Criteria: * Impossibility to answer to the assessment tools * Medium intellectual disability (homogenous IQ \< 75) * Presence of a grave somatic disease (cancer, cardiac failure, renal failure, central nervous system disorder), that is progressive or that affects the vital prognosis in the short term * Active participation to another study

What they're measuring

Change from Baseline self-rated mental health status (need for care) at 2 years

Timeframe: Change from Baseline HoNOSCA before transition at 17 y.o. to after transition at 19 y.o.

Change from Baseline self-rated measure of quality of life at 2 years

Timeframe: Change from Baseline WHO-QoL before transition at 17 y.o. to after transition at 19 y.o

Trial details

NCT IDNCT04333797

SponsorQueen Fabiola Children's University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-31

View on ClinicalTrials.gov More Transitional Care trials